Literature DB >> 7986176

Factors affecting course and survival in Alzheimer's disease. A 9-year longitudinal study.

L Bracco1, R Gallato, F Grigoletto, A Lippi, V Lepore, G Bino, M P Lazzaro, F Carella, T Piccolo, C Pozzilli.   

Abstract

OBJECTIVE: To evaluate mean survival and to identify prognostic factors in a cohort of patients with Alzheimer's disease (AD).
DESIGN: Multicentric 9-year cohort analytic study.
SETTING: Seven neurology departments throughout Italy between April 1982 and January 1984. PATIENTS: We recruited a consecutive sample of 145 patients affected by probable AD (Multicenter Italian Study on Dementia protocol, National Institute of Neurological Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria). Five were misdiagnosed, and 21 could not participate in the longitudinal study. The clinicodemographic characteristics of the 119 enrolled patients (49 men, 70 women; mean age, 64.7 years; SD, 4.1 years; mean duration of disease, 3.1 years; SD, 1.8 years) did not differ from those of the 26 excluded patients. All underwent extensive cliniconeuropsychological testing every 6 months for at least 2 years until the patient died or our survey ended (April 30, 1991). Mean follow-up was 5.1 years (SD, 2.5 years). MAIN OUTCOME MEASURES: Death, severe functional impairment (a score > or = 17 on the Blessed Dementia Scale), and severe cognitive impairment (a score of < or = 7 on the Information-Memory-Concentration Test).
RESULTS: Survival curves obtained by the Kaplan-Meier method indicated that (1) patients with early- and late-onset disease (ie, before or after age 65 years) showed no difference either in relative survival or in time to reach predetermined functional and cognitive end points; (2) severely aphasic patients became profoundly demented significantly sooner than those with mild to moderate aphasia (P < .0001). Among clinicodemographic variables analyzed by a Cox model, severe language disability and functional loss proved to be the best predictors of death independent of age at onset or degree of dementia.
CONCLUSIONS: Age at onset did not influence course and survival in AD. Severe aphasia appears to be the best predictor of death and unfavorable course.

Entities:  

Mesh:

Year:  1994        PMID: 7986176     DOI: 10.1001/archneur.1994.00540240057016

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

1.  Predictors of mortality in patients with Alzheimer's disease living in nursing homes.

Authors:  G Gambassi; F Landi; K L Lapane; A Sgadari; V Mor; R Bernabei
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

2.  Alzheimer's disease: halothane induces Abeta peptide to oligomeric form--solution NMR studies.

Authors:  Pravat K Mandal; Jay W Pettegrew; Dennish W McKeag; Ratna Mandal
Journal:  Neurochem Res       Date:  2006-06-29       Impact factor: 3.996

3.  Curcumin Targeted, Polymalic Acid-Based MRI Contrast Agent for the Detection of Aβ Plaques in Alzheimer's Disease.

Authors:  Rameshwar Patil; Pallavi R Gangalum; Shawn Wagner; Jose Portilla-Arias; Hui Ding; Arthur Rekechenetskiy; Bindu Konda; Satoshi Inoue; Keith L Black; Julia Y Ljubimova; Eggehard Holler
Journal:  Macromol Biosci       Date:  2015-06-02       Impact factor: 4.979

Review 4.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

5.  Ginkgo biloba extract EGb 761 in the treatment of dementia: a pharmacoeconomic analysis of the Austrian setting.

Authors:  Michael Rainer; Hermann Mucke; Sandra Schlaefke
Journal:  Wien Klin Wochenschr       Date:  2013-01-05       Impact factor: 1.704

6.  Verbal fluency predicts mortality in Alzheimer disease.

Authors:  Stephanie Cosentino; Nikolaos Scarmeas; Steven M Albert; Yaakov Stern
Journal:  Cogn Behav Neurol       Date:  2006-09       Impact factor: 1.600

7.  Cognition and incident dementia hospitalization: results from the atherosclerosis risk in communities study.

Authors:  Andrea L C Schneider; Rebecca F Gottesman; Thomas Mosley; Alvaro Alonso; David S Knopman; Josef Coresh; A Richey Sharrett; Elizabeth Selvin
Journal:  Neuroepidemiology       Date:  2012-10-22       Impact factor: 3.282

8.  Race/ethnic differences in AD survival in US Alzheimer's Disease Centers.

Authors:  K M Mehta; K Yaffe; E J Pérez-Stable; A Stewart; D Barnes; B F Kurland; B L Miller
Journal:  Neurology       Date:  2007-11-14       Impact factor: 9.910

9.  Quantifying synchrony patterns in the EEG of Alzheimer's patients with linear and non-linear connectivity markers.

Authors:  Markus Waser; Heinrich Garn; Reinhold Schmidt; Thomas Benke; Peter Dal-Bianco; Gerhard Ransmayr; Helena Schmidt; Stephan Seiler; Günter Sanin; Florian Mayer; Georg Caravias; Dieter Grossegger; Wolfgang Frühwirt; Manfred Deistler
Journal:  J Neural Transm (Vienna)       Date:  2015-09-28       Impact factor: 3.575

10.  Should EOAD patients be included in clinical trials?

Authors:  Kinga Szigeti; Rachelle S Doody
Journal:  Alzheimers Res Ther       Date:  2011-02-08       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.